ARCTNasdaq Israel
Market cap
$210.615 M
$7.41 +21.88%
Close of 7 Aug 2026
Revenue
$82.0M
#2584 by revenue
Earnings
-$65.8M
Loss-making
Shares outstanding
28,423,069
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Arcturus Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.